According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 6.76%. At the end of 2024 the company had an Operating Margin of 1.24%.
Year | Operating Margin | Change |
---|---|---|
2024 | 1.24% | -86.71% |
2023 | 9.31% | 9.86% |
2022 | 8.48% | -25.98% |
2021 | 11.45% | -720.42% |
2020 | -1.85% | -130.34% |
2019 | 6.08% | -50.4% |
2018 | 12.27% | 48.23% |
2017 | 8.28% | 24.09% |
2016 | 6.67% | -181.53% |
2015 | -8.18% | -187.12% |
2014 | 9.39% | 9.87% |
2013 | 8.55% | -48.92% |
2012 | 16.73% | -36.08% |
2011 | 26.18% | -7.71% |
2010 | 28.37% | 9.49% |
2009 | 25.91% | -38.25% |
2008 | 41.96% | -12.43% |
2007 | 47.92% | 12.14% |
2006 | 42.73% | 8.78% |
2005 | 39.28% | -4.35% |
2004 | 41.07% | -0.54% |
2003 | 41.29% | 11.12% |
2002 | 37.15% | 36.07% |
2001 | 27.30% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 18.78% | 177.81% | ๐บ๐ธ USA |
![]() Sanofi SNY | 15.12% | 123.67% | ๐ซ๐ท France |
![]() Pfizer PFE | 12.60% | 86.39% | ๐บ๐ธ USA |
![]() Novartis NVS | 28.02% | 314.50% | ๐จ๐ญ Switzerland |
![]() Seagen
SGEN | -30.69% | -553.99% | ๐บ๐ธ USA |
![]() Dr. Reddy's Laboratories RDY | 23.99% | 254.88% | ๐ฎ๐ณ India |
![]() Amgen AMGN | 19.48% | 188.17% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 13.32% | 97.04% | ๐ฌ๐ง UK |
![]() Merck MRK | 31.06% | 359.47% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.